Role of BK channels in testosterone-induced relaxation of the aorta in spontaneously hypertensive rats

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 8, 2007, Pages 1477-1480

  Unemoto, Tamao ^a   Matsushita, Mayumi ^a   Tamura, Kazuhiro ^a   Tanaka, Yoshio ^b   Koike, Katsuo ^b   Kogo, Hiroshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

BK channel; Endothelium; Iberiotoxin; Indomethacin; Spontaneously hypertensive rat (SHR); Testosterone

Indexed keywords

ADENOSINE TRIPHOSPHATE; IBERIOTOXIN; INDOMETACIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; NORADRENALIN; PROTEIN INHIBITOR; TESTOSTERONE; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HYPERPOLARIZATION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; VASODILATATION; WISTAR KYOTO RAT;

ANIMALS; AORTA, THORACIC; ENDOTHELIUM, VASCULAR; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PEPTIDES; POTASSIUM CHLORIDE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TESTOSTERONE; TETRAETHYLAMMONIUM COMPOUNDS; VASOCONSTRICTOR AGENTS;

EID: 34548050895     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1477     Document Type: Article

References (17)

1. Goetz R. M., Thatte H. S., Prabhakar P., Cho M. R., Michel T., Golan D. E., Proc. Natl. Acad. Sci. U.S.A., 96, 2788-2793 (1999).
2. Unemoto T., Honda H., Kogo H., Eur. J. Pharmacol., 472, 61-67 (2003).
3. Nagao T., Illiano S., Vanhoutte P. M., Am. J. Physiol., 263, H1090-H1094 (1992).
4. Yue P., Chatterjee K., Beale C., Poole-Wilson P. A., Collins P., Circulation, 91, 1154-1160 (1995).
5. Costarella C. E., Stallone J. N., Rutecki G. W., Whittier F. C., J. Pharmacol. Exp. Ther., 277, 34-39 (1996).
6. Honda H., Unemoto T., Kogo H., Hypertension, 34, 1232-1236 (1999).
7. Nelson M. T., Quayle J. M., Am. J. Physiol., 268, C799-C822 (1995).
8. Triggle C. R., Hollenberg M., Anderson T. J., Ding H., Jiang Y., Ceroni L., Wiehler W. B., Ng E. S., Ellis A., Andrews K., McGuire J. J., Pannirselvam M., J. Smooth Muscle Res., 39, 249-267 (2003).
9. Rusch N. J., De Lucena R. G., Wooldridge T. A., England S. K., Cowley A. W., Jr., Hypertension, 19, 301-307 (1992).
10. Asano M., Masuzawa-Ito K., Matsuda T., Imaizumi Y., Watanabe M., Ito K., Am. J. Physiol., 265, H843-H851 (1993).
11. Simoncini T., Genazzani A. R., Eur. J. Endocrinol., 143, 281-292 (2003).
12. Tamura K., Honda H., Mimaki Y., Sashida Y., Kogo H., Br. J. Pharmacol., 121, 1796-1802 (1997).
13. Jensen B. S., Strobaek D., Olesen S. P., Christophersen P., Curr. Drug Targets, 2, 401-422 (2001).
14. Prieto D., Rivera L., Benedito S., Recio P., Villalba N., Hernandez M., Eur. J. Pharmacol., 531, 232-237 (2006).
15. Deenadayalu V. P., White R. E., Stallone J. N., Gao X., Garcia A. J., Am. J. Physiol., 281, H1720-H1727 (2001).
16. Won E., Won J., Kwon S., Lee Y., Nam T., Ahn D., Yonsei Med. J., 44, 1027-1033 (2003).
17. Tanaka Y., Koike K., Toro L., J. Smooth Muscle Res., 40, 125-153 (2004).